Dutasteride in localised prostate cancer management

Home » Dutasteride in localised prostate cancer management
Active Surveillance / By /

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

Interpretation

Dutasteride could provide a beneficial adjunct to active surveillance for men with low-risk prostate cancer.

Click here for full article.

Leave a Comment

Scroll to Top